Kohei Shitara. "Reply to: Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-02148